Alison co-heads our international Life Sciences and Healthcare group. She works with international life sciences companies to cut through the complexity of EU regulation of medical devices and pharmaceuticals, and get their products to market.

In a career of over 20 years, Alison has helped hundreds of life sciences companies manage the range of legal challenges involved in commercialising medical devices and medicinal products. She combines an encyclopaedic knowledge of the EU and UK life sciences regulatory environment with an analytical understanding of strategy and business in the life sciences sector. 

Alison provides sophisticated advice on regulation, compliance and commercialisation, as well as intellectual property transactions. On a number of occasions, she has successfully persuaded regulators and notified bodies to reconsider and ultimately overturn their decisions, allowing her clients to commercialise new products.

Alison supports clients on outright acquisitions and licences, as well as in due diligence for sizeable corporate transactions and listings. She also helps clients navigate the nuances of structuring and negotiating arrangements with various commercial and health care partners within the complex framework of EU regulations, national laws and industry and deontological codes. 

Her clients praise the pragmatism and commercial awareness she brings to every legal challenge and transaction, as well as her bright and personable working style. She is an accomplished leader, having built new life sciences practices for two top-tier London law firms.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Taylor Wessing confirms its intention to open in the Republic of Ireland to pursue tech and life science opportunities

9 avril 2021

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Edison Open House Global Healthcare 2021 – key takeaways from our panel

4 février 2021
Quick read

par plusieurs auteurs

Cliquer ici pour en savoir plus
Brexit

Brexit – what's the deal for business?

12 janvier 2021
Briefing

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Will the UK government's COVID-19 dosing regime gamble pay off?

11 janvier 2021
Briefing

par Alison Dennis et Justyna Ostrowska

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser